CARRIER-DEPENDENT AND CARRIER-INDEPENDENT TRANSPORT OF ANTICANCER ALKYLATING-AGENTS

[1] BEGLEITER A, 1977, CANCER RES, V37, P1022

[2] A COMPARISON OF MELPHALAN TRANSPORT IN HUMAN-BREAST CANCER-CELLS AND LYMPHOCYTES INVITRO [J]. CANCER LETTERS, 1980, 10 (03) : 243 - 251

[3] Bergsagel D E, 1967, Adv Cancer Res, V10, P311, DOI 10.1016/S0065-230X(08)60081-0

[4] BERGSAGEL DE, 1968, CAN MED ASSOC J, V98, P532

[5] BERGSAGEL DE, 1971, CAN MED ASSOC J, V104, P31

[6] LIMITED PROLIFERATION OF STEM-CELLS SURVIVING ALKYLATING-AGENTS [J]. NATURE, 1976, 262 (5563) : 68 - 70

[7] BRUCE WR, 1967, J NATL CANCER I, V38, P401

[8] BRUCE WR, 1966, JNCI-J NATL CANCER I, V37, P233

[9] BRUCE WR, 1969, JNCI-J NATL CANCER I, V42, P1015

[10] BYFIELD JE, 1981, P AM ASSOC CANC RES, V22, P229

[1] BEGLEITER A, 1977, CANCER RES, V37, P1022

[2] A COMPARISON OF MELPHALAN TRANSPORT IN HUMAN-BREAST CANCER-CELLS AND LYMPHOCYTES INVITRO [J]. CANCER LETTERS, 1980, 10 (03) : 243 - 251

[3] Bergsagel D E, 1967, Adv Cancer Res, V10, P311, DOI 10.1016/S0065-230X(08)60081-0

[4] BERGSAGEL DE, 1968, CAN MED ASSOC J, V98, P532

[5] BERGSAGEL DE, 1971, CAN MED ASSOC J, V104, P31

[6] LIMITED PROLIFERATION OF STEM-CELLS SURVIVING ALKYLATING-AGENTS [J]. NATURE, 1976, 262 (5563) : 68 - 70

[7] BRUCE WR, 1967, J NATL CANCER I, V38, P401

[8] BRUCE WR, 1966, JNCI-J NATL CANCER I, V37, P233

[9] BRUCE WR, 1969, JNCI-J NATL CANCER I, V42, P1015

[10] BYFIELD JE, 1981, P AM ASSOC CANC RES, V22, P229